Translator Disclaimer
1 October 2007 Differential Radiation Effect in Tumor and Normal Tissue after Treatment with Ramipril, an Angiotensin-Converting Enzyme Inhibitor
Author Affiliations +
Abstract

Kohl, R. R., Kolozsvary, A., Brown, S. L., Zhu, G. and Kim, J. H. Differential Radiation Effect in Tumor and Normal Tissue after Treatment with Ramipril, an Angiotensin-Converting Enzyme Inhibitor. Radiat. Res. 168, 440–445 (2007).

The angiotensin-converting enzyme inhibitor, ramipril, has been shown to mitigate radiation injury in normal tissues. Using A549 cell xenografts grown in athymic mice, we measured the effect of ramipril on radiation damage to tumors. Ramipril did not alter tumor response to radiation despite different times of drug administration with respect to radiation delivery (drug started 2 weeks before or immediately after irradiation). In contrast, using the same dose, ramipril reduced normal tissue radiation injury (30 Gy × 2 or 6 Gy × 10) as assessed by a semi-quantitative scale of skin damage and relative leg contraction. The results indicate that ramipril could offer therapeutic gain due to its different effect on normal tissues and tumors.

Robert R. Kohl, Andrew Kolozsvary, Stephen L. Brown, Guopei Zhu, and Jae Ho Kim "Differential Radiation Effect in Tumor and Normal Tissue after Treatment with Ramipril, an Angiotensin-Converting Enzyme Inhibitor," Radiation Research 168(4), (1 October 2007). https://doi.org/10.1667/RR0707.1
Received: 23 August 2006; Accepted: 1 April 2007; Published: 1 October 2007
JOURNAL ARTICLE
6 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top